What Researchers Did
Researchers are conducting a randomized clinical trial to investigate whether hyperbaric oxygen therapy can safely act as an anti-inflammatory treatment for COVID-19.
What They Found
This paper presents a hypothesis, noting that anecdotal evidence and two published case reports suggest promising results for hyperbaric oxygen therapy in COVID-19. The authors indicate that small prospective clinical trials are underway, including their own randomized clinical trial, which has not yet reported findings.
What This Means for Canadian Patients
If future research, including this ongoing randomized trial, confirms the safety and efficacy of hyperbaric oxygen therapy, it could offer a novel anti-inflammatory treatment option for Canadian patients with COVID-19. However, as the study is still in progress, it is too early to draw definitive conclusions or recommend changes to current clinical practice.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
A key limitation is that this paper presents a hypothesis and preliminary observations, with the main randomized clinical trial still underway and no definitive results reported.